Vaxart reports positive data from preclinical studies of oral avian flu vaccine (Pharmaceutical Business Review) Vaxart, a biotechnology company focused on the development of oral vaccines, has announced positive efficacy results from preclinical studies of the companys oral avian flu vaccine. [News Source]